Skip to content
Search

Latest Stories

RPS shares Covid-19 resources with Commonwealth

The Royal Pharmaceutical Society (RPS) has shared Covid-19 webinar resources with members of the Commonwealth Pharmacists Association (CPA).

The webinars are made available on Wednesday (July 1) as a CPD package to all CPA members across the globe, the pharmacy body has said in a press release.


“Upon successful completion of related CPD quiz, CPA members will also receive certificate for their records,” RPS added.

All webinars follow a Q&A format focusing on practical tips and sharing good practice.

RPS CEO Paul Bennett said: “I am delighted that RPS and CPA have collaborated to bring this valuable resource to members of the CPA, many of whom already enjoy access to our high-quality professional development materials and networks.

“The RPS mission is to put pharmacy at the forefront of healthcare and by working with CPA in this way we believe we are taking another step forward in achieving this. I would encourage you to access these resources so that you can join us and the CPA in the fight against Covid-19”.

CPA, Executive Director Victoria Rutter, said: “This is an exciting and welcome development that reflects the ongoing and growing partnership between the CPA and the RPS.

“We thank the RPS, as one of our own member organisations, for their ongoing support and hope that the webinars prove a valuable resource for pharmacists around the Commonwealth and beyond, supporting them to upskill and enhance their own practice for the benefit of patients as they continue their essential work as key workers on the front line tackling Covid-19.”

CPA Trustee and RPS English Pharmacy Board Chair, Claire Anderson, said: “As a Trustee of the CPA and Chair of the RPS English Pharmacy Board, I am delighted that RPS and CPA are collaborating on sharing Covid-19 resources.

“Traffic to the RPS Covid-19 hub has doubled during the pandemic and the resources including the regular clinical webinars have been invaluable to many people. I now hope many more colleagues around the globe will be able to benefit too.”

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less